Furthermore, our extensive characterization of clinical manifestations, properties of immune cells, and changes in function of the encoded enzyme, PLCγ2, support a definitive diagnosis of PLCγ2-associated antibody deficiency and immune dysregulation syndrome, designated as APLAID. Here, PLCG2 is linked to autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.